Next-generation LMP2A-targeting TCR-recombinant T cells with inducible IL-18 expression to treat EBV-associated malignancies
Molecular Therapy: Oncology
· Elsevier
Аннотация
Publication date: 17 September 2026 Source: Molecular Therapy Oncology, Volume 34, Issue 3 Author(s): Agnes Bonifacius, Philip Mausberg, Friederike Floegel, Anna Christina Dragon, Sabine Tischer-Zimmermann, Sven Stoll, Pegah Rahmati, Peter Spieler, María Fernanda Lammoglia Cobo, Anne Halenius, Hinrich Abken, Rainer Blasczyk, Thomas Nerreter, Michael Hudecek, Axel Schambach, Leo Hansmann, Britta Maecker-Kolhoff, Britta Eiz-Vesper
Читать у издателя →
Цитировать
Получайте новые статьи по теме «Медицинская фармакология»
Подписка, поиск по ключевым словам и избранное — в Telegram-боте Articlium.
Открыть в Telegram
Цитирование
✕
ГОСТ
APA
MLA
BibTeX
Next-generation LMP2A-targeting TCR-recombinant T cells with inducible IL-18 expression to treat EBV-associated malignancies. // Molecular Therapy: Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2950329926001414?dgcid=rss_sd_all
Next-generation LMP2A-targeting TCR-recombinant T cells with inducible IL-18 expression to treat EBV-associated malignancies. Molecular Therapy: Oncology. https://www.sciencedirect.com/science/article/pii/S2950329926001414?dgcid=rss_sd_all
“Next-generation LMP2A-targeting TCR-recombinant T cells with inducible IL-18 expression to treat EBV-associated malignancies.” Molecular Therapy: Oncology.
@article{article119285,
title = {Next-generation LMP2A-targeting TCR-recombinant T cells with inducible IL-18 expression to treat EBV-associated malignancies},
journal = {Molecular Therapy: Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2950329926001414?dgcid=rss_sd_all}
}